Skip To Main Content
Yingda L. Xie on Muck Rack

Yingda L. Xie

As seen in: Frontiers, Science Magazine, The Lancet, Healio
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingda L.

Contact Yingda L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Xpert MTB/RIF Ultra versus mycobacterial growth indicator tube liquid culture for detection of Mycobacterium tuberculosis in symptomatic adults: a diagnostic accuracy study

|
By Yingda L. Xie, Cape Town, Christie Eichberg, Nchimunya Hapeela
| The Lancet Verified
Summary Xpert MTB/RIF Ultra (Ultra) is an automated molecular test for the detection of Mycobacterium tuberculosis in sputum. We compared the sensitivity of Ultra to that of mycobacterial growth indicator tube (MGIT) liquid culture, considered the most sensitive assay in routine clinical use.
Open in Who Shared Issue with article?

Q&A: Negative PCR tests 'should not preclude evidence-based COVID-19 treatment'

|
By Maria Marabito, Yingda L. Xie
| Healio Primary Care Verified
February 23, 2022 4 min read Save Source/Disclosures Source: Healio Interview Disclosures: Xie reports no relevant financial disclosures. Please see the study for all other authors' relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later.
Open in Who Shared Issue with article?

Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis

|
By Lori E. Dodd, Yingda L. Xie, Ray Y. Chen, Praveen Paripati
| Science Magazine Verified
Imaging early TB drug responses Monitoring bacterial counts in the sputum of individuals with tuberculosis (TB) during 2 weeks of drug treatment is a key part of developing new TB drugs. However, such studies do not always correlate with the clinical response seen during a full 6-month drug regimen. Xie et al. performed these studies for three first-line TB drugs as well as moxifloxacin.
Open in Who Shared Issue with article?
See all 4 articles